George A Calin Selected Research

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

1/2018	Roles and clinical implications of microRNAs in acute lymphoblastic leukemia.
5/2010	Reprogramming of miRNA networks in cancer and leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

George A Calin Research Topics

Disease

272	Neoplasms (Cancer) 03/2024 - 01/2003
41	Neoplasm Metastasis (Metastasis) 11/2023 - 09/2007
38	Carcinogenesis 01/2023 - 06/2006
27	Breast Neoplasms (Breast Cancer) 01/2023 - 03/2003
25	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2024 - 08/2005
18	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 01/2003
14	Leukemia 03/2022 - 01/2005
13	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 09/2007
12	Lung Neoplasms (Lung Cancer) 01/2023 - 08/2005
9	Carcinoma (Carcinomatosis) 01/2023 - 01/2003
8	Prostatic Neoplasms (Prostate Cancer) 02/2017 - 08/2008
7	Disease Progression 03/2024 - 08/2014
7	Sepsis (Septicemia) 01/2023 - 10/2009
7	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 05/2011
7	Hypoxia (Hypoxemia) 01/2020 - 03/2007
6	Colonic Neoplasms (Colon Cancer) 01/2023 - 08/2007
6	Triple Negative Breast Neoplasms 03/2022 - 03/2015
5	Stomach Neoplasms (Stomach Cancer) 11/2023 - 02/2010
5	Inflammation (Inflammations) 07/2023 - 01/2015
5	Squamous Cell Carcinoma of Head and Neck 01/2023 - 09/2013
5	Lymphoma (Lymphomas) 10/2020 - 01/2005
5	Adenocarcinoma 08/2016 - 08/2008
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 12/2015
4	Infections 10/2022 - 01/2005
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021 - 03/2008
4	Urinary Bladder Neoplasms (Bladder Cancer) 02/2021 - 09/2007
4	Microsatellite Instability 12/2020 - 08/2007
4	Hepatocellular Carcinoma (Hepatoma) 11/2018 - 07/2007
4	Chromosome Aberrations (Chromosome Abnormalities) 04/2016 - 03/2008
4	Hematologic Neoplasms (Hematological Malignancy) 01/2015 - 01/2008
4	Inborn Genetic Diseases (Disease, Hereditary) 02/2011 - 09/2007
3	Melanoma (Melanoma, Malignant) 12/2023 - 03/2015
3	Chromosomal Instability (Chromosome Stability) 01/2023 - 09/2013
3	Adenocarcinoma of Lung 01/2022 - 02/2017
3	Brain Neoplasms (Brain Tumor) 05/2019 - 01/2008
3	Glioma (Gliomas) 01/2016 - 07/2013
3	Neuroblastoma 07/2015 - 03/2010
3	Adenoma (Adenomas) 12/2011 - 08/2005
2	Communicable Diseases (Infectious Diseases) 11/2023 - 03/2013
2	Genomic Instability 01/2023 - 01/2022
2	Mouth Neoplasms (Oral Cancer) 01/2023 - 01/2020
2	Rett Syndrome (Rett's Disorder) 03/2022 - 10/2010
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2020 - 10/2013
2	Multiple Myeloma 01/2020 - 01/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 05/2017

Drug/Important Bio-Agent (IBA)

237	MicroRNAs (MicroRNA)IBA 03/2024 - 07/2005
60	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2003
53	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2008
28	Long Noncoding RNAIBA 01/2023 - 01/2011
18	RNA (Ribonucleic Acid)IBA 01/2023 - 12/2007
17	Messenger RNA (mRNA)IBA 01/2023 - 08/2007
15	Untranslated RNA (Noncoding RNA)IBA 12/2023 - 09/2007
13	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2003
10	Phosphotransferases (Kinase)IBA 01/2023 - 03/2010
9	Immune Checkpoint InhibitorsIBA 11/2022 - 05/2018
7	Circular RNAIBA 11/2023 - 01/2018
5	Estrogens (Estrogen)FDA Link 01/2023 - 08/2005
5	AntigensIBA 08/2022 - 07/2015
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 05/2009
4	Insulin-Like PeptidesIBA 12/2023 - 10/2019
4	Small Interfering RNA (siRNA)IBA 05/2022 - 11/2013
4	AntagomirsIBA 01/2022 - 01/2015
4	Trastuzumab (Herceptin)FDA Link 01/2018 - 01/2012
4	Epidermal Growth Factor (EGF)IBA 01/2018 - 01/2003
3	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 07/2015
3	Histones (Histone)IBA 01/2023 - 10/2013
3	AntibodiesIBA 11/2022 - 01/2017
3	NucleotidesIBA 01/2021 - 07/2007
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 09/2013
3	Hormones (Hormone)IBA 12/2019 - 03/2010
3	human ERBB2 proteinIBA 01/2017 - 05/2012
3	Therapeutic UsesIBA 01/2016 - 07/2013
2	ArrestinIBA 12/2023 - 01/2021
2	Protein Isoforms (Isoforms)IBA 12/2023 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 07/2023 - 01/2023
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2023 - 01/2011
2	CytokinesIBA 10/2022 - 01/2018
2	ChemokinesIBA 10/2022 - 12/2020
2	Peptides (Polypeptides)IBA 11/2021 - 01/2020
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021 - 01/2020
2	AndrogensIBA 01/2021 - 08/2008
2	Nerve Growth Factor (NGF)IBA 01/2021 - 12/2020
2	CateninsIBA 01/2021 - 12/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2020 - 01/2018
2	Cadherins (E-Cadherin)IBA 10/2020 - 11/2004
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 04/2020 - 01/2017
2	Glutamine (L-Glutamine)FDA Link 01/2020 - 02/2016
2	Antisense OligonucleotidesIBA 05/2019 - 01/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019 - 01/2017
2	NF-kappa B (NF-kB)IBA 10/2018 - 01/2015
2	ElementsIBA 07/2018 - 11/2004

Therapy/Procedure

82	Therapeutics 11/2023 - 08/2005
19	Drug Therapy (Chemotherapy) 12/2023 - 05/2012
5	Immunotherapy 01/2023 - 01/2019
5	Radiotherapy 02/2022 - 12/2015
3	Precision Medicine 01/2022 - 05/2012
2	Neoadjuvant Therapy 07/2023 - 05/2012
2	Punctures 01/2023 - 01/2022
2	Ligation 01/2023 - 01/2022
2	RNAi Therapeutics 01/2022 - 06/2014